Kiyoshi Nishioka Selected Research

Kiyoshi Nishioka Research Topics

Disease

8	Sclerosis 02/2007 - 01/2002
5	Inflammation (Inflammations) 08/2006 - 07/2003
4	Atopic Dermatitis (Atopic Eczema) 08/2006 - 01/2002
4	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2005 - 01/2003
3	Contact Dermatitis (Eczema, Contact) 04/2007 - 09/2003
3	Fibrosis (Cirrhosis) 12/2004 - 07/2003
2	Seasonal Allergic Rhinitis (Hay Fever) 04/2007 - 01/2006
2	Urticaria (Hives) 08/2006 - 09/2003
2	Skin Diseases (Skin Disease) 08/2006 - 09/2003
2	Eosinophilia 09/2005 - 09/2003
1	Food Hypersensitivity (Food Allergy) 06/2007
1	Erythema 04/2007
1	Synovial Sarcoma (Synovioma) 02/2007
1	Carcinogenesis 02/2007
1	Anaphylaxis (Anaphylactic Shock) 07/2006
1	Hypersensitivity (Allergy) 07/2006
1	Hypercholesterolemia 10/2005
1	Melanoma (Melanoma, Malignant) 02/2005
1	Vascular System Injuries 02/2005
1	Arthralgia (Joint Pain) 02/2005
1	Erythema elevatum diutinum 01/2005
1	Thyroiditis 01/2005
1	Disease Progression 12/2004
1	Eccrine Porocarcinoma 01/2004
1	Bowen's Disease (Disease, Bowen) 01/2004
1	Arthritis (Polyarthritis) 01/2004
1	Localized Scleroderma (Morphea) 09/2003
1	Edema (Dropsy) 04/2003
1	Trichophyton infection 01/2003
1	Tinea Pedis (Athlete's Foot) 01/2003
1	Warts (Wart) 01/2003
1	Allergic Rhinitis 10/2002
1	Pulpitis 06/2002
1	Periodontitis 06/2002

Drug/Important Bio-Agent (IBA)

9	Bleomycin (Blenoxane)FDA LinkGeneric 02/2007 - 01/2002
5	Immunoglobulin E (IgE)IBA 04/2007 - 08/2005
3	CytokinesIBA 09/2003 - 09/2003
2	AntigensIBA 04/2007 - 08/2005
2	Proteins (Proteins, Gene)FDA Link 02/2007 - 02/2005
2	P-SelectinIBA 08/2006 - 01/2002
2	SelectinsIBA 09/2005 - 01/2002
2	LigandsIBA 09/2005 - 01/2002
2	Etretinate FDA Link 02/2005 - 01/2004
2	CollagenIBA 03/2004 - 09/2003
2	Messenger RNA (mRNA)IBA 01/2004 - 09/2003
2	Tacrolimus (Prograf)FDA LinkGeneric 09/2003 - 01/2003
2	Transforming Growth Factor beta (TGF-beta)IBA 07/2003 - 01/2002
1	AllergensIBA 06/2007
1	Indicators and Reagents (Reagents)IBA 06/2007
1	SYT-SSX fusion proteinIBA 02/2007
1	prostaglandin D2 receptorIBA 08/2006
1	Prostaglandin D2IBA 08/2006
1	Prostaglandins DIBA 08/2006
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 08/2006
1	HaptensIBA 08/2006
1	Prostaglandins AIBA 07/2006
1	AlbuminsIBA 10/2005
1	lipoprotein cholesterolIBA 10/2005
1	Hemoglobins (Hemoglobin)IBA 10/2005
1	HLA-B51 AntigenIBA 07/2005
1	bucillamine (SA 96)IBA 02/2005
1	mizoribineIBA 02/2005
1	Immunomodulating AgentsIBA 02/2005
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2005
1	Methotrexate (Mexate)FDA LinkGeneric 02/2005
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 02/2005
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2005
1	Antiphospholipid AntibodiesIBA 01/2005
1	Interleukin-13IBA 12/2004
1	Therapeutic UsesIBA 09/2004
1	PicibanilIBA 09/2004
1	Fas Ligand Protein (Fas Ligand)IBA 01/2004
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2004
1	Caspase 3 (Caspase-3)IBA 01/2004
1	Collagen Type I (Type I Collagen)IBA 09/2003
1	suplatast tosilateIBA 09/2003
1	Interleukin-4 (Interleukin 4)IBA 09/2003
1	Interleukin-5 (Interleukin 5)IBA 09/2003
1	emedastine FDA Link 09/2003
1	azelastine (Optivar)FDA LinkGeneric 09/2003
1	Ointments (Pastes)IBA 09/2003
1	Anti-Allergic Agents (Antiallergic Agents)IBA 09/2003
1	Histamine Antagonists (Antihistamines)IBA 09/2003
1	Histamine (Histamine Dihydrochloride)FDA Link 09/2003
1	Neutralizing AntibodiesIBA 09/2003
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2003
1	Amyloid (Amyloid Fibrils)IBA 09/2003
1	Picryl Chloride (Trinitrochlorobenzene)IBA 09/2003
1	indium-bleomycinIBA 07/2003
1	Antithyroid Agents (Antithyroid Drugs)IBA 04/2003
1	GlycosaminoglycansIBA 04/2003
1	Dust (House Dust)FDA Link 01/2003
1	Granzymes (Granzyme)IBA 01/2003
1	Antifungal AgentsIBA 01/2003
1	Interleukin-12 (IL 12)IBA 06/2002

Therapy/Procedure

5	Injections 05/2005 - 01/2002
3	Therapeutics 01/2004 - 01/2003
1	Lasers (Laser) 02/2005
1	Subcutaneous Injections 12/2004
1	Oral Administration 09/2003